Evidence map›Paper›PMID 42534265›Full record

ArticleMedComm2026

PD-1

Haojie Xu, Wanki Ho, Lulu Cao, Dongdong Fu, Yun Li, Feng Sun, Xi Xu, Zhanguo Li, Ru Li, Hua Ye and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in MedComm, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Haojie XuDepartment of Rheumatology and Immunology Peking University People's Hospital Beijing China.ORCID https://orcid.org/0000-0002-2201-074X
Wanki HoDepartment of Rheumatology and Immunology Peking University People's Hospital Beijing China.
Lulu CaoDepartment of Rheumatology and Immunology Peking University People's Hospital Beijing China.
Dongdong FuDepartment of Rheumatology and Immunology Peking University People's Hospital Beijing China.
Yun LiDepartment of Rheumatology and Immunology Peking University People's Hospital Beijing China.
Feng SunDepartment of Rheumatology and Immunology Peking University People's Hospital Beijing China.
Xi XuDepartment of Rheumatology and Immunology Peking University People's Hospital Beijing China.
Zhanguo LiDepartment of Rheumatology and Immunology Peking University People's Hospital Beijing China.
Ru LiDepartment of Rheumatology and Immunology Peking University People's Hospital Beijing China.
Hua YeDepartment of Rheumatology and Immunology Peking University People's Hospital Beijing China.
Huaqun ZhuDepartment of Rheumatology and Immunology Peking University People's Hospital Beijing China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid arthritis (RA) remains a challenging autoimmune disease with variable treatment responses to tumor necrosis factor-α (TNF-α) inhibitors. This study investigates the clinical significance of PD-1

Indexed as

disease activityefficacy predictionrheumatoid arthritisTNF‐α inhibitorT peripheral helper cell

Identifiers

PMID42534265
PMCPMC13420207

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.